Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6049 - 6056 of 12082 results

A Rundown of Recent State Action Relating to Medicaid Expansion
June 4, 2018| Blog| Viewpoint

ML Strategies Health Care Preview - June 4, 2018
June 4, 2018| Blog| Viewpoint

Is SEP Licensing Up To Standard?
June 4, 2018| News

Supreme Court Rules on Class Action Waivers in Arbitration Agreements
June 1, 2018| News

5Pointz and the Visual Artists Rights Act of 1990
June 1, 2018| Blog| Viewpoint

White Collar, Regulatory & Compliance Trailblazers
May 31, 2018| News

Smartphone Wars – The Last Jury: Samsung Owes $539M for Infringing Apple’s Patents
May 31, 2018| Blog| Viewpoint
News & Press Releases
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
IP Strategist Daniel Brownstone Joins Mintz in New York
July 30, 2025
Daniel Brownstone has joined Mintz as a Member in the firm’s Intellectual Property Division, adding depth to the firm’s IP Prosecution Practice and contributing to its continued growth in the market. He will be based in the firm’s New York office.
Intelligize referenced a recent article by Mintz Member Jacob Hupart in its coverage of the ongoing court challenges to the Securities and Exchange Commission’s climate disclosure rule. Jacob’s piece examines the Eighth Circuit’s decision to hold litigation over the rule “in abeyance.”
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
